NCT00573521View on ClinicalTrials.gov

Risk Factors for Piperacillin/Tazobactam Resistance in Extended-Spectrum Beta-Lactamase (ESBL) Producing Organisms

CompletedOBSERVATIONAL
Enrollment

450

Participants

Timeline

Start Date

November 30, 2007

Primary Completion Date

June 30, 2017

Study Completion Date

June 30, 2017

Conditions
Enterobacteriaceae Infections
Trial Locations (1)

15213

UPMC, Pittsburgh

All Listed Sponsors
lead

University of Pittsburgh

OTHER

NCT00573521 - Risk Factors for Piperacillin/Tazobactam Resistance in Extended-Spectrum Beta-Lactamase (ESBL) Producing Organisms | Biotech Hunter | Biotech Hunter